Search
Now showing items 1-10 of 124
Understanding the drivers of value creation for biopharmaceuticals around the time of drug launch
(Massachusetts Institute of Technology, 2012)
The purpose of this research is to investigate potential strategic variables that executives at small to mid-sized biopharmaceutical companies should consider during the period of a drug launch. Bringing a product to market ...
The contribution of disease focused nonprofits to biomedical research and development
(Massachusetts Institute of Technology, 2013)
Patient-centered, disease-focused nonprofits are playing an increasingly prominent role in accelerating the development of new diagnostics, drugs, and therapies. They are engaging in a variety of complex venture philanthropic ...
Disease marketing and patient coping : a research study
(Massachusetts Institute of Technology, 2012)
BACKGROUND: There is a high prevalence of disease marketing actions in the United States that are targeted towards patients with chronic illness. However, no study has assessed the direct effects of these marketing actions ...
Mathematical and mechanical modeling of vaso-occlusion in sickle cell disease
(Massachusetts Institute of Technology, 2007)
Vaso-occlusive crises cause most of the morbidity and mortality associated with sickle cell disease. The proximal causes of these occlusive events are not well understood. The risks and consequences of vaso-occlusion however ...
Genomics research and cultivating serendipity in pharmaceutical drug discovery : assessing the competitiveness of R&D productivity between the West and Asia
(Massachusetts Institute of Technology, 2007)
It has been widely reported that pharmaceutical drug discovery innovation began its major decline somewhere in the last decade of the 20th century. After reaching a historical high of 53 new molecular entities (NMEs) in ...
Green fluorescent protein as a mechanical sensor
(Massachusetts Institute of Technology, 2007)
Inquiry into intracellular and cytoskeletal mechanics requires an intracellular mechanical sensor to verify models of sub-cellular structure dynamics. To this end, the green fluorescent protein (GFP) is considered as a ...
Development of a chronically implanted microelectrode array for intraneural electrical stimulation for prosthetic sensory feedback
(Massachusetts Institute of Technology, 1999)
The functionality of prosthetic limbs is restricted by the limited availability of sensory feedback. This research aims to develop a technology to allow the presentation of sensory information directly to the sensory ...
DMA : a diabetes disease management system
(Massachusetts Institute of Technology, 2003)
There is a clear and present need to improve the quality of diabetes care. Information technology can be used as a means to that end. In this article, we discuss the design and implementation of a web-based diabetes ...
Organizational design : the integration of pharmaceutical discovery and development
(Massachusetts Institute of Technology, 2004)
The decline in Pharmaceutical R&D productivity has been attributed to high clinical failure rates suggesting that targets, leads and clinical candidates may be of lower quality in recent years. Senior R&D management generally ...
Managing revisions of rules and guidelines used in clinical information systems : exploring a hierarchical knowledge representation model
(Massachusetts Institute of Technology, 2004)
One important purpose for creating clinical practice guidelines is to improve quality of care by reducing variations in practice. In the current healthcare environment, guidelines are being advocated as a means to disseminate ...